Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2026)

Solid Biosciences has reported Interest & Investment Income for 9 years, with the latest figure at $2.1 million in Q1 2026.

• Quarterly Interest & Investment Income fell 10.26% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 1.83% YoY) and the FY2025 annual result came in at $9.9 million, up 4.59% from the prior year.
• Interest & Investment Income rose to $2.1 million in Q1 2026 per SLDB's latest filing, from $2.1 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.6 million in Q3 2025 and troughed at -$40000.0 in Q2 2025.
• A 5-year average of $1.2 million and a median of $1.5 million in 2022 frame the typical range for Interest & Investment Income.
• The widest YoY moves for Interest & Investment Income: up 12205.26% in 2025, down 263.64% in 2025.
• Over 5 years, Interest & Investment Income stood at $1.5 million in 2022, then rose by 14.73% to $1.8 million in 2023, then increased by 9.38% to $1.9 million in 2024, then advanced by 6.6% to $2.1 million in 2025, then grew by 0.58% to $2.1 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $2.1 million, $2.1 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.